All news

ResMed CEO sells 4,993 shares after option exercise

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

ResMed's Chairman and CEO, Michael J. Farrell, recently exercised options for 4,993 common shares at

Read original source

RMD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.